Ticker Report Natixis Advisors LLC raised its stake in Vaxcyte, Inc. (NASDAQ:PCVX - Free Report) by 6.5% during the second quarter, according to the company in its most recent Form 13F filing with the Securities...\n more…
Ticker Report Vaxcyte (NASDAQ:PCVX - Get Free Report) had its price target boosted by equities research analysts at Mizuho from $113.00 to $163.00 in a report released on Tuesday, Benzinga reports. The firm...\n more…
Ticker Report Shares of Vaxcyte, Inc. (NASDAQ:PCVX - Get Free Report) hit a new 52-week high during mid-day trading on Tuesday after Mizuho raised their price target on the stock from $113.00 to $163.00. Mizuho...\n more…
Globe Newswire SAN CARLOS, Calif., Sept. 11, 2024 (GLOBE NEWSWIRE) -- Vaxcyte, Inc. (Nasdaq: PCVX), a clinical-stage vaccine innovation company engineering high-fidelity vaccines to protect humankind from the...\n more…
Ticker Report Arizona State Retirement System increased its stake in shares of Vaxcyte, Inc. (NASDAQ:PCVX - Free Report) by 4.1% during the second quarter, according to the company in its most recent disclosure...\n more…